Lecture 8 - B Cell Immunity 1 - Microimm 2500

B Cell Immunity Overview

Learning Objectives

  • Understand B cell development.

    • Structure and generation of BCRs and antibodies through gene rearrangement.

    • Mechanisms of self-reactive B cell elimination via negative selection.

  • Explore the structure and function of antibody classes: IgM, IgD, IgG, IgE, IgA.

  • Learn effector mechanisms associated with different antibody classes.

  • Distinguish between natural and artificial passive immunity.

What Are Antibodies?

  • Antibodies are soluble polypeptide molecules produced and secreted by B cells.

  • immune system can make antibodies in response to infections

    • have a broad range of effector function

  • b cells can recognize any type of substance

  • Functions:

    • Neutralizing pathogens and cytotoxic actions (cell-mediated and complement-mediated).

    • Capable of recognizing a wide array of substances.

    • Significant medical and commercial importance.

Bestselling Drugs (2024)

  • Humanized Monoclonal Antibodies:

    • Keytruda (Merck & Co.): $27.2 billion

    • Ozempic (Novo Nordisk): $16.1 billion

    • Dupixent (Sanofi): $13.5 billion

    • Eliquis (BMS/Pfizer): $13.3 billion

    • Biktarvy (Gilead): $12.6 billion

    • Darzalex (J&J): $12 billion

    • Opdivo (BMS/Ono): $11.3 billion

    • Comirnaty (Pfizer/BioNTech): $10.8 billion

    • Gardasil (Merck & Co./CSL): $10 billion

    • Skyrizi (AbbVie): $9.9 billion

  • ones marked with asterisk are antibodies called monoclonal antibodies bcs they are engineered to bind to specific antigens, providing targeted immune responses and enhancing the body's ability to fight infections.

B Cell Receptors and Antibodies

  • Consist of four polypeptide chains linked by disulfide bonds.

  • made up of four polypeptide chains

    • 2 immunoglobulin chains and 2 light chain proteins

    • linked by disulfide bonds

    • light chain

      • kappa

      • lamda

      • can use either or

    • variable region of the immunoglobulin chains is responsible for antigen recognition and binding, allowing B cells to produce a diverse range of antibodies.

      • has two distinct antigen binding site… heavy chain and light chain working together

    • constant region of the immunoglobulin chains determines the antibody's class and mediates its effector functions, such as activating complement or binding to Fc receptors on other immune cells.

  • Components:

    • Light Chains: kappa (κ) or lambda (λ).

    • Heavy Chains: µ, δ, γ, α, or ε.

    • Antibody types are classified based on heavy chains.

  • antibodies can be broken up into regions

  • hinge region is flexible giving antibody a lot of flexibility

  • modified by various carbohydrate chains

  • antibody types are determined by which heavy chain they use

    • ex. IGM antibody uses mu heavy chain

  • antibodies and b cell receptors are the same molecules but with differences in their structure and function; while antibodies are secreted into the bloodstream to neutralize pathogens, B cell receptors are membrane-bound forms that allow B cells to recognize specific antigens.

  • development of antibodies (soluble) development is done by colonel selection

  • encoded by immunoglobulin genes

Antibody Structure

  • B cell receptor (BCR) vs. Antibody:

    • (a) Membrane-bound form (BCR).

    • (b) Secreted form (antibody).

  • Components:

    • Iga, IgB

    • Spacer, hydrophilic segment, hydrophobic segment, cytosolic segment.

  • heavy chain has 1 variable region and 3 constant regions in this antibody

  • VDJ (immunoglobulin heavy gene) for heavy chain

    • genetic recombination is happening to make the variations of B cell receptors (BCRs) that allow for the diverse recognition of antigens.

  • VJ (immunoglobulin kappa or lambda) for light chain

  • 1million base pair longs so very long gene that encodes for the unique heavy chain of the antibody, allowing for a diverse range of antigen recognition.

Gene Rearrangement in Antibodies

  • Antibody heavy and light chain proteins are encoded by V, D, J, and C gene segments.

B Cell Development in the Bone Marrow

  • Stages include Pro-B, Immature, Transitional B Cell stages.

  • IgH VDJ rearrangement, followed by Igκ/λ VJ rearrangement.

  • Results in diverse BCR specificities.

  • all b cells are generated in the bone marrow

  • progenitor b cells undergo several stages of maturation before they can express functional immunoglobulin on their surface.

  • if rearrangement is successful will show pre_BCR on surface of cell, indicating that the B cell is ready to progress to the next maturation phase. This pre-BCR is crucial for signaling and further development into a mature B cell capable of producing antibodies.

  • Once mature, B cells can migrate to secondary lymphoid organs, where they can encounter antigens and undergo further activation and differentiation into plasma cells or memory B cells.

    • made up of heavy chain and some light cell chains

  • immunoglobulin kappa or lambda light chains are rearranged… if successful light chain protein can be made and paired with heavy chain

    • can recognize molecules but are very sensitive at this time and can cause cell death when meeting ligands with high affinity. This affinity maturation process ensures that only the B cells with the highest affinity for the antigen will survive and proliferate, ultimately leading to a robust immune response.

  • B cells don’t require antigen presentation, they can recognize any type of substance

Activation of Naive B Cells

  • never engaged with antigen before

  • Activation occurs via:

    • T-Independent (TI) mechanisms.

      • engagement of recognition of antigen activates and activating signal… must receive a second signal by a pattern recognition receptor to fully activate the B cell, allowing it to proliferate and differentiate into antibody-secreting plasma cells.

    • T-Dependent (TD) mechanisms using cytokines and T helper cells.

      • require activation by t cells, which provide necessary signals for B cell differentiation and antibody production.

      • more complicated

      • t cells and b cells need to recognize each other

      • b cell interacts w/ antigen through bcr and will phagocytose that antigen, leading to the processing and presentation of antigen fragments on MHC class II molecules to T helper cells, which subsequently release cytokines that further stimulate B cell activation and proliferation.

      • t cell recognizes peptide on b cell and will deliver costimulatory receptors, which are crucial for the full activation of the B cell, enhancing its ability to produce antibodies and develop into memory cells.

      • CD40 expressed by b cell and CD40Ligand expressed by t cell

      • only happens if b cell and t cell are in close contact which happens if t cell recognizes peptide on b cell

  • both need signal from bcr

Maturation and Clonal Selection of B Cells

  • Development leads to antibody-secreting plasma cells or memory cells.

  • Differentiation involves:

    • Gene rearrangement.

    • Clonal deletion (removal of self-reactive B cells).

  • can make more than one type of antibody

  • memory cells are formed after an initial immune response and can rapidly produce antibodies upon re-exposure to the same antigen.

Effector Mechanisms of Antibodies

  1. Neutralization: Prevents pathogen binding.

  2. Agglutination: Clumping of pathogens.

    1. cross link particles and can do glutination making large complexes of a tigens

  3. Opsonization: Enhances phagocytosis.

  4. Complement Activation: Lysis of pathogens.

    1. antibody is trigger activation of complement cascade

  5. Antibody-Dependent Cell-mediated Cytotoxicity (ADCC): Induces destruction of infected cells.

    1. infected cell / cancer cell is being recognized by antibody molecules cell natural killer cells, leading to the targeted destruction of these cells through the release of cytotoxic granules.

  6. Degranulation: Release of cytotoxic substances from immune cells.

    1. granulocytes degranulate and release substances such as histamine and proteolytic enzymes, which play a crucial role in amplifying the immune response and combating infections.

Production of Antibody Classes

  • Heavy-chain C-region genes determine the Ig class.

  • switch constant region gene segment to a different one (doesn’t happen in bone marrow)

    • during immune response it can switch use of constant region segments to encode different antibody classes (VDJ segment stays the same, constant region switches only)

IgM Structure and Function

  • First antibody produced (primary response).

  • it can form y shaped version w 2 binding sites but can also can exist as a pentamer, which allows it to have ten binding sites, enhancing its ability to agglutinate pathogens and activate the complement system.

  • Exists as a monomer (2 binding sites) or pentamer (10 binding sites).

  • Efficient in agglutinating antigens and initiating classical complement pathway.

  • can bind in planar conformation (stick straight out), or staple form (pointing down)

IgD Structure and Function

  • Expressed along with IgM by immature B cells.

  • don’t know much about it

  • can express IgM and IgD simultaneously, allowing them to participate in the initial immune response while also contributing to the maturation of B cells into more specialized forms.

  • used as marker for immature b cells

  • Constitutes only 0.2% of circulating antibodies with unclear function.

IgG Structure and Function

  • Most prevalent antibody type in serum.

  • Long-lived with multiple subclasses (IgG1-4).and most abundant

  • dominate immune response second time you are exposed to something

  • 4 subclasses

    • each have slightly different functions

  • Effective in activating phagocytosis and complement pathways.

IgA Structure and Function

  • Found in secretions like saliva, mucus, and breast milk.

    • mainly pressent in secretions

    • how its passed to babies and increase their immune system

  • Present predominantly as dimeric form (two subclasses: IgA1, IgA2).

    • IgA neutralizes pathogens but doesn’t do much else

  • Neutralizes pathogens but does not opsonize or activate complement.

IgA Transport Across Epithelial Barriers

  • Dimeric IgA is actively transported into the gut lumen, neutralizing pathogens and toxins.

  • actively transported across epithelial cells

    • has receptor pIgR, which facilitates its transcytosis and secretion into mucosal surfaces, playing a crucial role in mucosal immunity.

IgE Structure and Function

  • Associated with allergic reactions and asthma, produced in minimal quantities yet potent.

  • Activates mast cells, basophils, and eosinophils.

  • responsible for allergies

  • made in small quantities but very potent

  • interacts with specific receptors and releases histamine, which contributes to the inflammatory response and exacerbates allergic reactions.

Blood Group Antigens and Antibodies

  • Example of self-nonself discrimination.

  • b cells subject to clonal deletion

  • self non-self discrimination is a crucial mechanism that ensures B cells only respond to foreign antigens, preventing autoimmune reactions and maintaining immune system balance.

  • ABO blood types:

    • Type A: A antigen, anti-B antibodies

      • have carbohydrate antigen A on blood cells

    • Type B: B antigen, anti-A antibodies

    • Type AB: Both antigens, no antibodies

    • Type O: No antigens, both anti-A and anti-B antibodies.

Natural Passive Immunity

  • Transfer of IgG antibodies from mother to fetus through FcRn receptors during pregnancy.

  • Post-birth, secretory IgA antibodies transferred via breastmilk.

  • when you get antibodies from someone else

    • ex. pregnancy… antibodies go from mother to fetus

      • same with through breast milk

      • whatever mother is resistant to will make baby also resistant to it

Artificial Passive Immunity

  • Intravenous Immunoglobulin (IVIG) treatments for antibody deficiencies.

  • Use of humanized monoclonal antibodies for disease treatment and viral neutralization.

  • patient infused w antibodies given to patients with antibody deficiencies

Summary

  • BCR specificities generated through immunoglobulin gene rearrangement during B cell development.

  • Self-reactive B cells eliminated via negative selection.

  • Antibodies recognize diverse antigens not restricted by MHC.

  • Different antibody classes perform specialized functions crucial for immunity.

robot